Xu et al. found that IGF2BP3 promotes lung cancer progression by maintaining the mRNA stability of anti-ferroptotic factors in an m6A-dependent manner (GPX4, SLC3A2, ACSL3, and FTH1) [103]. This evidence concerns the gene IGF2BP3 and lung carcinoma.